🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Baxalta Innovations GmbH — Licensed Medicines

15 medicines held by Baxalta Innovations GmbH on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 15 products held by Baxalta Innovations GmbH
MedicineActive substanceLicence holderStatus
ADYNOVI 1000 IU Powder and solvent for solution for injection
EU/1/17/1247/010-012
Rurioctocog alfa pegol Baxalta Innovations GmbH
ADYNOVI 2000 IU Powder and solvent for solution for injection
EU/1/17/1247/013-014
Rurioctocog alfa pegol Baxalta Innovations GmbH
ADYNOVI 250 IU Powder and solvent for solution for injection
EU/1/17/1247/001-004
Rurioctocog alfa pegol Baxalta Innovations GmbH
ADYNOVI 3000 IU Powder and solvent for solution for injection
EU/1/17/1247/015-016
Rurioctocog alfa pegol Baxalta Innovations GmbH
ADYNOVI 500 IU Powder and solvent for solution for injection
EU/1/17/1247/005-008
Rurioctocog alfa pegol Baxalta Innovations GmbH
Cuvitru 200 mg/ml solution for subcutaneous injection
PA2004/008/001
Human normal immunoglobulin Baxalta Innovations GmbH Marketed
FEIBA 100 U/ml powder and solvent for solution for infusion
PA2004/001/003
Factor VIII inhibitor bypassing fraction Baxalta Innovations GmbH Marketed
FEIBA 50 U/ml powder and solvent for solution for infusion
PA2004/001/002
Feiba Baxalta Innovations GmbH Not marketed
Flexbumin 200 g/l solution for infusion
PA2004/002/001
Human plasma protein Baxalta Innovations GmbH Marketed
Human Albumin Baxalta 200 g/l Solution for Infusion
PA2004/004/002
Plasma protein containing at least 95% human albumin Baxalta Innovations GmbH Not marketed
Human Albumin Baxalta 50 g/l Solution for Infusion
PA2004/004/001
Plasma protein containing at least 95% human albumin Baxalta Innovations GmbH Marketed
HyQvia 100 mg/mL solution for infusion for subcutaneous use
EU/1/13/840/001-006
Human normal immunoglobulin Baxalta Innovations GmbH
Prothromplex TOTAL 500 IU powder and solvent for solution for injection
PA2004/005/002
Human coagulation factor ii, Human coagulation factor vii, Human coagulation factor ix, Human coagulation factor x, Human Protein C Baxalta Innovations GmbH Marketed
VEYVONDI 1300 IU powder and solvent for solution for injection
EU/1/18/1298/002
VONICOG ALFA Baxalta Innovations GmbH
VEYVONDI 650 IU powder and solvent for solution for injection
EU/1/18/1298/001
VONICOG ALFA Baxalta Innovations GmbH
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.